A REVIEW ON OMICRON (VOC) PREVENTION, GLOBAL RISK ASSESSMENT AND EFFECTIVENESS OF COVID-19 VACCINES AGAINST OMICRON

Ravi Kumar; Gaurav Kumar; Ramesh Chaudhary; Rajat Dhariwal

Ravi Kumar S.D. College of Pharmacy & Vocational Studies, Muzaffarnagar (UP) India
Gaurav Kumar Dr. KN Modi Institute of Pharmaceutical Education and Research (U.P.) India.
Ramesh Chaudhary Department of Pharmacy, Shri Venkateshwara University, Gajraula, Uttar Pradesh, India
Rajat Dhariwal S.D. Group of Colleges, Muzaffarnagar (UP) India

Keywords: Omicron, SARS-CoV, spike protein, vaccine, Sympathomimitic, antibody, immature B cell

Abstract

According to recent study, researchers found a Novel form of corona virus in November. The variant name is given SAR-COV omicron (B.1.1.529).it is higher number of mutation 26-32 spike. First case of omicron found in South Africa on November 9th. There exists a restricted statistics at the Omicron variant. Overall the synchronized dynamics of Omicron is greater complicated than CoV-2 or its variants like Delta. The sudden end result is that while Omicron will be greater contagious than even Delta, it might be a whole lot much less dangerous. This short note gives the highlights to identification and global spread of OMICRON which has spread over more than 150 nations by now, the detection of mutations with inside the RBD area of Spike protein is a challenge by surpassing vaccine immunity. Before had will speak approximately its transmission potentiality, infectivity, sickness morbidity in addition to its effect on COVID‐19 vaccines. This article gives the information about the spike protein sequence that found in sub-clade of omicron.